Welcome to the RQA International QA Conference - our first ever virtual conference
10TH-12TH NOV 2020
Join us for a varied programme with a focus on our conference theme '20/20 Vision: A New Frontier?' from the comfort of your desk. As usual we will be running plenary sessions, GxP streams, QA Clinics and more. We will have a large, free exhibition area for anyone who wishes to attend, a poster display and a range of virtual networking tools, such as 1:1 chat, chatrooms, discussions and a community lounge.
If you are new to virtual conferencing, please visit A Virtual Conference for more information on what to expect.
All live presentations will be available on the conference platform as on-demand videos after the event for 30 days, so wherever you are in the world, the whole conference will be accessible to you. All attendees will have access to the content after the initial 30 days on the RQA website.
Our Keynote Speaker this year is Kriss Akabusi and he will be speaking on 10th November.
EARLY BIRD PRICING
Ends 31st August 2020
MEMBER £574.00 (standard price £689.00)
NON- MEMBER £799.00 (standard price £911.00)
with the option of applying for free membership until end December 2021 after the event
(All prices exclude UK VAT)
Free Virtual Exhibition
We are offering the chance for anyone to come into the virtual exhibition hall for no charge (no delegate registration required). You will be able to access the exhibition for the duration of the conference, which will cover all time zones.
As QA professionals we have always had to be adaptable and during these challenging times even more so and have to look at adopting and embracing new ways of auditing and doing quality is one of the themes coming out of the conference. We invite you to join us on and be part of this new frontier.
Andrew Waddell - THE MULTICULTURAL AUDITOR
Currently Andrew is Managing Director of Tower Mains Limited and prior to that was the Head of Quality and Training at Inveresk Research. A regular lecturer in Europe, Japan and the USA, he has wide experience of working with government and industry bodies and was an adviser to the OECD during the development of the original OECD Principles of Good Laboratory Practice.
Ann Meeker O'Connell - OPTIMISING TRIAL DESIGN AND RISK-BASED OVERSIGHT THROUGH QUALITY BY DESIGN
Ann is Vice President at Vertex, previous experience includes being Global Head of QA at IQVIA, with more than 20 years of clinical and biomedical research experience in government, academia and industry. She worked for FDA for four years and holds a bachelor’s degree in biological anthropology and anatomy and a master’s degree in pharmacology from Duke University
Tim Menard - AI: QUALITY CHALLENGES
Tim Menard is a PharmD with a specialisation in pharmaceutical medicine. He started his industry career in 2009 in Pharmacovigilance (PV) and had different roles in PV that brought him to live in various parts of the world (Switzerland, Singapore and Germany). He has been leading the PD Quality Data Science Team at Roche since January 2018.
Andrew Gray - OECD DATA INTEGRITY
Andrew is Deputy Director - Inspection Enforcement and Standards with the MHRA. Andrew joined the MHRA in January 2003 as a GLP inspector, in May 2006 Andrew took on the role of Head of the United Kingdom Good Laboratory Monitoring Authority and in September 2014 Andrew was appointed Inspectorate Unit manager. He has also worked in both academia and the pharmaceutical industry.